BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 15283466)

  • 1. Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro.
    Gribova IY; Tillib SV; Tutykhina IL; Shmarov CE; Logunov DY; Verkhovskaya LV; Naroditskii BS; Gintsburg AL
    Acta Naturae; 2011 Jul; 3(3):64-70. PubMed ID: 22649695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deaminase deluge yields new opportunities for biotechnology and genome engineering.
    Harris RS; Carpenter MA
    Mol Cell; 2024 Mar; 84(5):816-818. PubMed ID: 38458171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis.
    Tiedemann K; Sadvakassova G; Mikolajewicz N; Juhas M; Sabirova Z; Tabariès S; Gettemans J; Siegel PM; Komarova SV
    Transl Oncol; 2019 Mar; 12(3):462-474. PubMed ID: 30583289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted deletion of the zebrafish actin-bundling protein L-plastin (lcp1).
    Kell MJ; Riccio RE; Baumgartner EA; Compton ZJ; Pecorin PJ; Mitchell TA; Topczewski J; LeClair EE
    PLoS One; 2018; 13(1):e0190353. PubMed ID: 29293625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effect of a replication-incompetent adenoviral vector with cytosine deaminase gene driven by L-plastin promoter in hepatocellular carcinoma cells.
    Jung K; Kim S; Lee K; Kim C; Chung I
    Arch Pharm Res; 2007 Jun; 30(6):770-7. PubMed ID: 17679557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
    Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
    Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
    Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
    Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
    Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
    Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K
    Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test.
    Chung I; Deisseroth AB
    Arch Pharm Res; 2004 Jun; 27(6):633-9. PubMed ID: 15283466
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.